Randomized Trial of Hyperimmune Globulin for Congenital CMV Infection - 2-Year Outcomes.
Hughes, Brenna L. M.D. 1; Clifton, Rebecca G. Ph.D. 2; Rouse, Dwight J. M.D. 1; Saade, George R. M.D. 3; Dinsmoor, Mara J. M.D., M.P.H. 4; Reddy, Uma M. M.D., M.P.H. 5; Pass, Robert M.D. 6; Allard, Donna R.N. 1; Mallett, Gail R.N. 4; MacPherson, Cora Ph.D. 2; Wapner, Ronald M.D. 7; Metz, Torri M.D. 8; Goodnight, William H. M.D. 9; Tita, Alan T.N. M.D., Ph.D. 6; Costantine, Maged M. M.D. 10; Swamy, Geeta K. M.D. 11; Heyborne, Kent D. M.D. 12; Chien, Edward K. M.D. 13; Chauhan, Suneet P. M.D. 14; El-Sayed, Yasser Y. M.D. 15; Casey, Brian M. M.D. 16; Parry, Samuel M.D. 17; Simhan, Hyagriv N. M.D. 18; Napolitano, Peter G. M.D. 19; Macones, George A. M.D. 20; for the Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network
[Letter]
New England Journal of Medicine.
389(19):1822-1824, November 9, 2023.
(Format: HTML, PDF)